Introduction

Surface Rendering of Neurofibromin in its Open and Closed Conformation

Neurofibromin is encoded by NF1 gene, located on chromosome 17. Neurofibromin functions as a tumor suppressor through its association with the protein Ras. The molecular structure of Neurofibromin has been determined by Cryo-Electron Microscopy. The structure of neurofibromin isoform 2 revealed different functional states for the Neurofibromin protein.^[1] Mutations in Neurofibromin areassociated with diseases such as Plexiform Neurofibromas.

Function

Neurofibromin functions as a tumor suppressor protein.^[2] It prevents cell growth by turning off Ras which in its active state, stimulates cell growth and division. Ras is a small, monomeric GTPase. Ras is membrane bound and insteracts with Neurofibromin, a cytoplasmic protein, in the open conformation of Neurofibromin. (DEFINE RAS) Neurofibromin is brought to the membrane to associate with Ras by SPRED1. (DEFINE SPRED1) Unlike Ras, Neurofibromin can interact with SPRED1 in both the open and closed conformations. The interaction between Neurofibromin and Ras is activated via an Arginine finger (Arg 1276) present in the GRD domain of Neurofibromin. Arg 1276 is only accessible for binding when the GRD and Sec14-PH domains are rotated into the open conformation. When Arg 1276 is able to associate with Ras, Neurofibromin downregulates the Ras signaling pathway by speeding up Ras's GTPase activity, hydrolyzing the GTP associated with Ras to GDP. In its GDP bound state, Ras is inactive and cell growth and division is inhibited. (MECHANISTIC EXPLANATION).

Mechanism of Ras Regulation by Neurofibromin

Structure

Neurofibromin is a made up of two identical chains. Neurofibromin has two conformations, open and closed. Shifting between these controls neurofibromins ability to associate with Ras (6ob3) and perform its function of Ras regulation. The transformation between the overall closed and open conformations transitions it from an active to inactive state. There are two important domains involved in the transition between the open and closed conformations, the domain and the domain. Although neurofibromin is a homodimer with two identical protomers, only one protomer has its GRD and Sec14-PH domains rotated into the open conformation.

Conformational States

Closed Conformation (7PGR)

In the , the GRD and Sec14-PH domains are rotated so Ras cannot bind. In this conformation, the GRD and Sec14-PH are inaccessible and inactive. Neurofibromin is held in the inactive state by a consisting of residues Cys 1032, His 1558, and His 1576 that form a transition metal-binding site with zinc. The rigid organization of the keeps the GRD domain packed tightly on top of the Heat Arms in the Neurofibromin core. This tight compaction sterically occludes Neurofibromin from associating with Ras. In its active form, Ras and Neurofibromin will associate via an (Arg 1276). However, the steric hindrance from the Neurofibromin core in the closed conformation inhibits this association. Therefore, in the closed conformation, neurofibromin cannot catalyze GTP hydrolysis by Ras and Ras continues to signal for cell growth and proliferation.

Open Conformation (7PGT)

In the , (REWRITE ABOUT RAS REGULATION)

This transition is initiated by movement of the transition metal-binding site. The Cys 1032, His 1558, and His 1576 Residues become separated and zinc is not able to bond. In the active form, one protomer has its GRD and Sec14-PH domains oriented oppositely from the inactive form. The GRD rotates -130° and the Sec14-PH domain rotates -90° (TOWARDS WHAT?) Due to this rotation, Cys 1032 is now located too far away, approximately 30 Å, from His 1558 and His 1576 which results in the loss of the metal-binding site and no formation of the . The lack of the transition metal-binding site allows the GRD to orient itself to associate with . This association positions the (TO DO WHAT?). When Neurofibromin is in the open, active conformation, Arg 1276 is able to because there is no steric hindrance from the Neurofibromin core.

Rotation of the GRD and Sec14-PH domains from the closed conformation of neurofibromin to the open conformation of neurofibromin to allow Ras binding. The GRD rotates -130° and the Sec14-PH domain rotates -90°

Disease and Medical Relevance

Currently over 1485 mutations of Neurofibromin have been identified that lead to life-threatening illnesses or conditions such as Neurofibromatosis Type I.^[3] Mutations to the NF1 gene that prevent the interaction of Neurofibromin with Ras, remove this check on Ras dependent cell proliferation and uncontrolled cell growth can lead to tumors and a higher risk of cancer. Neurofibromatosis Type 1, the most well-known disease resulting from mutations in Neurofibromin, is characterized by cognitive impairment, soft, non-cancerous tumors on or under the skin known as neurofibromas, birthmarks called cafe-au-lait macules, clusters of freckles in unusual places, and problems with the bones, eyes and nervous system.

Neurofibromin is an essential protein and is involved mainly in the differentiation of neural crest-derived cells, mesenchymal cells, neural cells, melanocytes, and bone cells. As Neurofibromin is essential for embryonic development, mutations to the NF1 gene can result in psychological retardation resulting from Type I neurofibromatosis. Most of the 1485 mutations identified lead to a synthesis of truncated, non-functional protein and are a result of point mutations. Type I Neurofibromatosis is inherited in an autosomal dominant manner but about 50% of cases de novo ones. ^[4]

Mutations of the gene NF1 can lead to major structural and functional changes that are dangerous for the patient. NF1 mutation(s) can result in the complete loss of function and the inability to interact with the Ras protein. If interaction with Ras cannot occur, no conversion of GTP to GDP occurs and, therefore, no inactivation of Ras. Consequently, there is nothing limiting Ras from promoting cell growth. Uncontrolled cell growth leads to tumors and puts patients at a much higher risk for cancer. Mutations in the NF1 gene have been found in sporadic cancers such as glioblastoma, neuroblastoma, lung cancer, ovarian cancer, and breast cancer. Additionally, NF1 is one of the top ten genes that are most mutated in tumors of the lung, breast, ovary, pancreas, and prostate. Researchers are still unsure as to whether biallelic loss of NF1 is common or if it is only a hemizygous loss of the gene that contributes to the growth progression of certain sporadic tumors. It is possible that the order of mutations affects the grade of a tumor (for certain types of cells) and thus explains why NF1 patients are not predisposed to certain types of sporadic tumors.^[5]

Student Contributors

• Hannah Luchinski
• Sophie Mullinix